Financial Statements

bluebird bio, Inc. (BLUE)

$3.16

+0.16 (+5.33%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) -2,901-2,282-1,499-914-
Net Income -819-619-790-556-336
Stock Dividends --7-29-578
Dividend Paid -----
Retained Earnings -3,720-2,901-2,282-1,499-914

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 347337247200-
Annual Depreciation -22339167103262
Capital Expenditure -23-29-76-56-62
Net PPE 101347337247200

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -13131313
New Purchases -686-1,518-757-1,004-451
Intangible and Goodwill 131313136

bluebird bio, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes bluebird bio, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.